ClinicalTrials.gov
public full text
Public Domain
Evaluating the Effect of Mucinex® 1200 mg on Mucociliary and Cough Clearance From the Human Lung
The purpose of this research study is to test the ability of Mucinex, an oral, over-the-counter, FDA approved expectorant) to stimulate the clearance of inhaled particles from the subject's lungs (called "mucociliary clearance"). The study will also monitor the metabolism of the drug by the subject's body.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Study of the Effect of 20 mg Ambroxol Hydrochloride on Acute Cough.#808097
- Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs#1171373
- Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis#898858
- Prevention of Oral Mucositis in Head and Neck Cancer.#992989
- Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets#1128215
Record · ID 1163905
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive